These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 16111194

  • 1. [Immunological tests: Anaphylatoxins C3a, C4a, C5a].
    Fujino S, Sakurabayashi I.
    Nihon Rinsho; 2005 Jul; 63 Suppl 7():80-3. PubMed ID: 16111194
    [No Abstract] [Full Text] [Related]

  • 2. [Anaphylatoxins C3a, C4a, C5a].
    Fujino S, Mori M, Sakurabayashi I.
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():82-5. PubMed ID: 20942007
    [No Abstract] [Full Text] [Related]

  • 3. Complement-derived anaphylatoxins in human donor corneas treated with excimer laser.
    Gardner BP, Pleyer U, Mondino BJ, Sumner HL, Frieberg ML, Imperia PS.
    Ophthalmic Surg Lasers; 1995 Jun; 26(6):568-71. PubMed ID: 8746579
    [Abstract] [Full Text] [Related]

  • 4. Thrombolytic treatment and complement activation.
    Agostoni A, Gardinali M, Frangi D, Cugno M, Cafaro C, Conciato L, Sponzilli C, Salmoirago E.
    Ann Ital Med Int; 1994 Jun; 9(3):178-9. PubMed ID: 7946896
    [Abstract] [Full Text] [Related]

  • 5. [Atopic dermatitis. II. The status of complement proteins and the pathogenetic role of anaphylatoxins C4a, C3a and C5a].
    Sergeev IuV, Reznikov IuP, Lobanova EV, Pimenova NS.
    Vestn Dermatol Venerol; 1989 Jun; (4):4-7. PubMed ID: 2788339
    [Abstract] [Full Text] [Related]

  • 6. Anaphylatoxin levels in human aqueous humor.
    Mondino BJ, Sumner H.
    Invest Ophthalmol Vis Sci; 1986 Aug; 27(8):1288-92. PubMed ID: 3488296
    [Abstract] [Full Text] [Related]

  • 7. Complement mediated inhibition of immune precipitation and solubilization generate different concentrations of complement anaphylatoxins (C4a, C3a, C5a).
    Schifferli JA, Steiger G, Paccaud JP.
    Clin Exp Immunol; 1986 May; 64(2):407-14. PubMed ID: 3488858
    [Abstract] [Full Text] [Related]

  • 8. Generation of human C3a, C4a, and C5a anaphylatoxins by protein A of Staphylococcus aureus and immobilized protein A reagents used in serotherapy of cancer.
    Langone JJ, Das C, Bennett D, Terman DS.
    J Immunol; 1984 Aug; 133(2):1057-63. PubMed ID: 6610702
    [Abstract] [Full Text] [Related]

  • 9. Demonstration of anaphylatoxins C3a, C4a and C5a in the scales of psoriasis and inflammatory pustular dermatoses.
    Takematsu H, Ohkohchi K, Tagami H.
    Br J Dermatol; 1986 Jan; 114(1):1-6. PubMed ID: 3484631
    [Abstract] [Full Text] [Related]

  • 10. Anaphylatoxin levels in human vitreous humor.
    Mondino BJ, Sidikaro Y, Sumner H.
    Invest Ophthalmol Vis Sci; 1988 Jul; 29(7):1195-8. PubMed ID: 3262096
    [Abstract] [Full Text] [Related]

  • 11. Serum complement levels and severity of sepsis.
    Nakae H, Endo S, Inada K, Takakuwa T, Kasai T, Yoshida M.
    Res Commun Chem Pathol Pharmacol; 1994 May; 84(2):189-95. PubMed ID: 8091004
    [Abstract] [Full Text] [Related]

  • 12. C3, C5 components and C3a, C4a, and C5a fragments of the complement system.
    Janatova J.
    Methods Enzymol; 1988 May; 162():579-625. PubMed ID: 3265757
    [No Abstract] [Full Text] [Related]

  • 13. Anaphylatoxins and terminal complement complexes in pancreatitis. Evidence of complement activation in plasma and ascites fluid of patients with acute pancreatitis.
    Roxvall LI, Bengtson LA, Heideman JM.
    Arch Surg; 1990 Jul; 125(7):918-21. PubMed ID: 2369318
    [Abstract] [Full Text] [Related]

  • 14. [Determination of C3a and C5a in hemapheresis procedures].
    Schooneman F, Marchand M, Vigneron C, Streiff F.
    Ann Med Interne (Paris); 1990 Jul; 141(7):597-9. PubMed ID: 2085237
    [Abstract] [Full Text] [Related]

  • 15. Complement activation in neonatal disease.
    Zilow EP.
    Eur J Pediatr; 1993 May; 152(5):459-60. PubMed ID: 8319722
    [No Abstract] [Full Text] [Related]

  • 16. Serum concentrations of complement anaphylatoxins and proinflammatory mediators in patients with 2009 H1N1 influenza.
    Ohta R, Torii Y, Imai M, Kimura H, Okada N, Ito Y.
    Microbiol Immunol; 2011 Mar; 55(3):191-8. PubMed ID: 21244468
    [Abstract] [Full Text] [Related]

  • 17. Complement factors c3a, c4a, and c5a in chronic obstructive pulmonary disease and asthma.
    Marc MM, Korosec P, Kosnik M, Kern I, Flezar M, Suskovic S, Sorli J.
    Am J Respir Cell Mol Biol; 2004 Aug; 31(2):216-9. PubMed ID: 15039137
    [Abstract] [Full Text] [Related]

  • 18. Complexes of IgG molecules and C3a and C4a complement components in human serum.
    Nezlin R, Freywald A.
    Eur J Immunol; 1992 Jul; 22(7):1955-7. PubMed ID: 1623933
    [Abstract] [Full Text] [Related]

  • 19. Lower circulating levels of complement split proteins C3a and C4a in maternal plasma of women with gestational diabetes mellitus.
    Lappas M.
    Diabet Med; 2011 Aug; 28(8):906-11. PubMed ID: 21615487
    [Abstract] [Full Text] [Related]

  • 20. Complement split products c3a and c4a in chronic lyme disease.
    Stricker RB, Savely VR, Motanya NC, Giclas PC.
    Scand J Immunol; 2009 Jan; 69(1):64-9. PubMed ID: 19140878
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.